Literature DB >> 20845530

Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al.

David S Finley1, Frederic Pouliot, Allan Pantuck.   

Abstract

Entities:  

Year:  2010        PMID： 20845530     DOI： 10.1016/j.eururo.2010.06.020

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  "New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy.

Authors:  Christopher Twelves; Javier Cortes; Peter A Kaufman; Louise Yelle; Ahmad Awada; Terri A Binder; Martin Olivo; James Song; Joyce A O'Shaughnessy; Maria Jove; Edith A Perez
Journal:  Breast Cancer Res       Date:  2015-12-09       Impact factor: 6.466
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.